logo
Select company
Select metric
$ -53.13MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
12
Sector
32
Industry
45
History
98
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information

Ticker

ABUS

Company Name

ARBUTUS BIOPHARMA CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARBUTUS BIOPHARMA CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABUS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 1.01M$ -54.14M$ -53.13M
3/31/2025$ 1.35M$ -76.45M$ -75.09M
12/31/2024$ 1.38M$ -69.78M$ -68.4M
9/30/2024$ 1.41M$ -76.55M$ -75.14M
6/30/2024$ 1.44M$ -76.92M$ -75.48M
3/31/2024$ 1.43M$ -74.08M$ -72.66M
12/31/2023$ 1.4M$ -72.39M$ -70.99M
9/30/2023$ 1.35M$ -74.75M$ -73.39M
6/30/2023$ 1.33M$ -71.83M$ -70.5M
3/31/2023$ 1.37M$ -68.61M$ -67.25M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) EBITDA stands at $ -65.15M.
  • Over the past 5 years, ARBUTUS BIOPHARMA CORP's average EBITDA has been $ -67.11M.
  • The median EBITDA for ARBUTUS BIOPHARMA CORP during this period was $ -67.15M
  • ARBUTUS BIOPHARMA CORP reached its highest EBITDA over the past 5 years at $ -53.13M.
  • The lowest EBITDA recorded by ARBUTUS BIOPHARMA CORP in the same timeframe $ -75.48M

ARBUTUS BIOPHARMA CORP's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ZBIO : ZENAS BIOPHARMA INC $ -175.83MQURE : UNIQURE NV $ -119.56MNUVB : NUVATION BIO INC $ -200.93MVIR : VIR BIOTECHNOLOGY INC $ -533.7MBCYC : BICYCLE THERAPEUTICS PLC $ -240.81MIMNM : IMMUNOME INC $ -209.77MRLAY : RELAY THERAPEUTICS INC $ -306.64MCAPR : CAPRICOR THERAPEUTICS INC $ -68.35MALMS : ALUMIS INC $ -232.06MTSHA : TAYSHA GENE THERAPIES INC $ -90.23M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ARBUTUS BIOPHARMA CORP is calculated as follows: EBIT [ $ -67.15M ] + DepAmor [ $ 2M ]
(=) EBITDA [ $ -65.15M ]

ABUS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -75.48M

Minimum

Jun 30, 2024

$ -53.13M

Maximum

Jun 30, 2025

$ -67.11M

Average

$ -67.15M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M